The Metabolic Syndrome, Coronary Artery Calcium Score and Cardiovascular Risk Reclassification

Fudim, Marat; Patel, Devin K.; Zalawadiya, Sandip; Kottam, Anupama; Alesh, Issa; Cardozo, Shaun; Afonso, Luís

doi:10.1016/s0735-1097(15)61357-2

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The outcome of interest was hard CVD (CVDh) events, which included participants with myocardial infarction, death due to myocardial infarction, resuscitated cardiac arrest, stroke and death from stroke. A comparable analysis of this data set focusing on the metabolic syndrome is already published [1] .…”

Section: Datamentioning

confidence: 99%

“…We evaluated the predictive accuracy for the ASCVD score for each participant in accord with the American College of Cardiology/American Heart Association guidelines using pooled cohort equations. Similar to the publication by Fudim et al “The Metabolic Syndrome, Coronary Artery Calcium Score and Cardiovascular Risk Reclassification” [1] the analytic properties of models incorporating the ASCVD score with and without CACS were compared for cardiovascular disease CVD prediction. Here the analysis focused on ASCVD score (with and without CACS) performance across gender and ethnicities.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Data on coronary artery calcium score performance and cardiovascular risk reclassification across gender and ethnicities

et al. 2016

Self Cite

View full text Add to dashboard Cite

The current guidelines recommend the new risk score, Atherosclerotic Cardiovascular Disease score (ASCVD), to assess an individual׳s risk of future cardiovascular disease (CVD) events. No data exist on the predictive utility of ASCVD score with the incremental value of coronary artery calcium scoring (CACS) across ethnicities and gender. Multi-Ethnic Study of Atherosclerosis (MESA) is a population based study (n=6814) of White (38%), Black (28%), Chinese (22%) and Hispanic (12%) subjects, aged 45–84 years, free from clinical cardiovascular disease. We performed a post-hoc analysis of 6742 participants (mean age 62, 53% female) from the MESA cohort. We evaluated the predictive accuracy for the ASCVD score for each participant in accord with the American College of Cardiology/American Heart Association guidelines using pooled cohort equations. Similar to the publication by Fudim et al. “The Metabolic Syndrome, Coronary Artery Calcium Score and Cardiovascular Risk Reclassification” [1] the analytic properties of models incorporating the ASCVD score with and without CACS were compared for cardiovascular disease CVD prediction. Here the analysis focused on ASCVD score (with and without CACS) performance across gender and ethnicities.

show abstract

Section: Datamentioning

confidence: 99%

mentioning

confidence: 99%